Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction

Autor:	Kurt Huber, Hannes Alber, Walter S. Speidl, Thomas W. Weiss, Josef Aichinger, Robert Zweiker, Norbert Watzinger
Jazyk:	angličtina
Rok vydání:	2016
Předmět:	Acute coronary syndrome medicine.medical_specialty Ticagrelor animal structures Myocardial Infarction Review Article 030204 cardiovascular system & hematology P2Y12 inhibitor Drug Administration Schedule 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Secondary Prevention Humans In patient 030212 general & internal medicine Myocardial infarction Intensive care medicine Secondary prevention Medicine(all) Evidence-Based Medicine Aspirin business.industry General Medicine medicine.disease Treatment Outcome Austria Practice Guidelines as Topic Cardiology Purinergic P2Y Receptor Antagonists Position paper DAPT business Platelet Aggregation Inhibitors
Zdroj:	Wiener Klinische Wochenschrift
ISSN:	1613-7671 0043-5325
Popis:	Summary The protective effect of dual antiplatelet therapy (DAPT) following acute coronary syndrome is undisputed, but its duration is subject of debate. Several studies show that prolonged therapy provides a clinical benefit in patients following acute coronary syndrome. The aim of this position paper authored by Austrian experts is to outline the current evidence and provide an overview of recent studies. It is also intended to serve as a practical guide to identify those patients who may benefit from prolonged DAPT.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e9ed063510b652ccfe3bd80a057453f http://europepmc.org/articles/PMC4916195 Zobrazit plný text záznamu Full text from SpringerLink